← PRUDENTIAL FINANCIAL INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | ($1.7b) | $2.5b | $2.8b | $3.7b | |
| Net Income (Loss) Attributable to Parent | $4.4b | $7.9b | $4.1b | $4.2b | ($374.0m) | $7.7b | ($1.4b) | $2.5b | $2.7b | $3.6b | |
| Net Income (Loss) Available to Common Stockholders, Basic | $4.4b | $7.8b | $4.0b | $4.1b | ($395.0m) | $7.6b | ($1.5b) | $2.5b | $2.7b | $3.5b | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | $7.9b | $4.0b | $4.1b | ($242.0m) | $7.7b | ($1.4b) | $2.5b | $2.7b | $3.6b | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $4.4b | — | — | — | $34.1b | $107.2b | $24.7b | $28.8b | $63.9b | $83.1b | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $0 | — | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $51.0m | $111.0m | $14.0m | $52.0m | $228.0m | $70.0m | ($24.0m) | $20.0m | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $4.4b | $8.0b | $4.1b | $4.2b | ($146.0m) | $7.8b | ($1.5b) | $2.5b | $2.8b | $3.7b | |
| Amortization of Intangible Assets | $116.0m | $51.0m | $61.0m | $65.0m | $102.0m | $110.0m | $104.0m | $89.0m | $80.0m | $73.0m | |
| Deferred Policy Acquisition Costs, Amortization Expense | $1.9b | $1.6b | $2.3b | $2.3b | $2.2b | $2.1b | $2.4b | $1.5b | $1.5b | $1.6b | |
| Depreciation, Depletion and Amortization | $318.0m | $222.0m | $161.0m | $460.0m | $457.0m | $204.0m | $124.0m | ($70.0m) | $383.0m | $128.0m | |
| Deferred Income Tax Expense (Benefit) | $700.0m | ($2.0b) | $480.0m | ($20.0m) | ($369.0m) | ($214.0m) | ($1.1b) | ($75.0m) | ($778.0m) | $398.0m | |
| Asset Impairment Charge | — | — | — | — | — | — | $903.0m | $177.0m | $0 | $0 | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | $1.1b | $903.0m | $177.0m | $0 | — | |
| Goodwill impairment | — | — | — | $0 | $0 | $1.1b | $903.0m | $177.0m | $0 | $0 | |
| Goodwill, Impairment Loss | — | — | — | — | — | $1.1b | $903.0m | $177.0m | — | $0 | |
| Share-based Payment Arrangement, Expense | $202.0m | $263.0m | $155.0m | $231.0m | $226.0m | $268.0m | $208.0m | $254.0m | $314.0m | $257.0m | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | $120.0m | ($72.0m) | ($57.0m) | ($25.0m) | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | — | — | $772.0m | $2.2b | $657.0m | $642.0m | $867.0m | $1.3b | |
| Income (Loss) from Equity Method Investments | $49.0m | $49.0m | $76.0m | $100.0m | $96.0m | $87.0m | ($56.0m) | $49.0m | $144.0m | $129.0m | |
| Income Tax Expense (Benefit) | $1.3b | ($1.4b) | $822.0m | $947.0m | ($81.0m) | $1.7b | ($370.0m) | $613.0m | $507.0m | $1.1b | |
| Additional Financial Items | |||||||||||
| (Gains) losses on assets supporting experience-rated contractholder liabilities, net | $17.0m | ($336.0m) | $863.0m | ($971.0m) | ($743.0m) | $299.0m | $1.1b | ($503.0m) | ($595.0m) | ($648.0m) | |
| Assets supporting experience-rated contractholder liabilities | ($33.3b) | ($39.0b) | ($27.3b) | ($14.6b) | ($30.8b) | ($21.4b) | ($11.8b) | ($2.3b) | ($1.8b) | ($1.9b) | |
| Assets transferred upon surrender of IRA contracts | — | — | — | — | — | $0 | $0 | $2.0b | $0 | $0 | |
| Beginning Cash Position | — | — | — | — | — | — | $12.9b | $17.3b | $19.5b | $18.5b | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | $4.9b | $7.7b | $19.4b | $20.8b | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | ($7.6b) | ($12.1b) | ($28.6b) | ($25.9b) | |
| Change In Other Working Capital | — | — | — | — | — | — | ($5.6b) | ($5.6b) | ($4.1b) | ($6.9b) | |
| Change In Working Capital | — | — | — | — | — | — | ($194.0m) | ($958.0m) | ($412.0m) | ($4.6b) | |
| Change in value of market risk benefits, net of related hedging (gains) losses | — | — | — | — | — | ($3.6b) | $409.0m | ($56.0m) | $397.0m | $475.0m | |
| Changes In Cash | — | — | — | — | — | — | $4.5b | $2.1b | ($689.0m) | $1.2b | |
| Commercial mortgage and other loans | ($8.5b) | ($8.9b) | ($10.3b) | ($10.7b) | ($6.1b) | ($9.4b) | ($5.5b) | ($6.4b) | ($9.1b) | ($9.6b) | |
| Common Stock acquired | ($2.0b) | ($1.2b) | ($1.5b) | ($2.5b) | ($500.0m) | ($2.5b) | ($1.5b) | ($1.0b) | ($1.0b) | ($1.0b) | |
| Deferred policy acquisition costs | ($968.0m) | ($1.2b) | ($597.0m) | ($634.0m) | ($542.0m) | ($451.0m) | $232.0m | ($869.0m) | ($1.1b) | ($1.2b) | |
| Deferred reinsurance gain | — | — | — | — | — | — | $0 | $0 | $363.0m | $0 | |
| Deferred reinsurance loss | — | — | — | — | — | $0 | $0 | ($240.0m) | ($1.1b) | $0 | |
| Deposit assets established for Policyholders' account balances ceded | — | — | — | — | — | $0 | $0 | ($3.7b) | $0 | ($6.4b) | |
| Derivatives, net | $314.0m | ($391.0m) | $26.0m | $1.0b | $1.3b | ($429.0m) | ($1.9b) | ($1.3b) | ($696.0m) | ($175.0m) | |
| End Cash Position | — | — | — | — | — | — | $17.3b | $19.5b | $18.5b | $19.7b | |
| Equity securities | ($3.3b) | ($3.0b) | ($3.3b) | ($2.8b) | ($3.2b) | ($4.4b) | ($3.5b) | ($4.3b) | ($6.6b) | ($8.5b) | |
| Financing Cash Flow | — | — | — | — | — | — | $4.9b | $7.7b | $19.4b | $20.8b | |
| Fixed maturities, available-for-sale | ($66.9b) | ($68.7b) | ($77.2b) | ($64.6b) | ($56.5b) | ($65.2b) | ($60.1b) | ($47.6b) | ($73.0b) | ($67.6b) | |
| Fixed maturities, held-to-maturity | $0 | $155.0m | ($9.0m) | $0 | $0 | $239.0m | $38.0m | $22.0m | $0 | $0 | |
| Fixed maturities, trading | $34.1b | $40.7b | ($1.1b) | ($876.0m) | ($1.4b) | ($5.7b) | ($659.0m) | ($4.2b) | ($7.0b) | ($6.3b) | |
| Free Cash Flow | — | — | — | — | — | — | $5.2b | $6.5b | $8.5b | $6.3b | |
| Future policy benefits and other insurance liabilities | $10.6b | $10.9b | $16.5b | $11.0b | $10.8b | $7.8b | $6.6b | $5.5b | $4.8b | $3.5b | |
| Gain Loss On Investment Securities | — | — | — | — | — | — | $2.7b | $950.0m | $3.6b | $996.0m | |
| General and Administrative Expense | $11.8b | $11.9b | $11.9b | $13.4b | $13.9b | $13.6b | $12.5b | $13.0b | $13.3b | $13.0b | |
| Goodwill | $833.0m | $843.0m | $863.0m | $3.0b | $3.0b | $1.8b | $876.0m | $1.1b | $1.1b | $1.1b | |
| Income Taxes | $618.0m | ($1.6b) | $49.0m | ($339.0m) | ($424.0m) | ($62.0m) | ($1.7b) | ($442.0m) | ($146.0m) | ($493.0m) | |
| Insurance Services Revenue | — | — | $2.2b | $2.6b | $2.7b | $2.3b | $2.5b | $2.2b | $2.1b | $2.0b | |
| Interest credited to policyholders' account balances | ($3.8b) | ($3.8b) | $3.2b | $4.9b | $4.5b | $3.5b | $2.3b | $4.0b | $4.6b | $5.1b | |
| Investing Cash Flow | — | — | — | — | — | — | ($7.6b) | ($12.1b) | ($28.6b) | ($25.9b) | |
| Liabilities assumed | $5.0b | $6.3b | $8.4b | $4.5b | $1.0b | $6.4b | $8.8b | $3.3b | $16.0b | $489.0m | |
| Market Risk Benefit, Change in Fair Value, Gain (Loss) | — | — | — | — | — | — | — | $56.0m | ($397.0m) | ($475.0m) | |
| Net Business Purchase And Sale | — | — | — | — | — | $132.0m | $422.0m | $0 | $0 | — | |
| Net cash received / (paid) | — | — | — | — | — | $1.0b | $518.0m | $1.0b | $3.7b | $303.0m | |
| Net change in financing arrangements (maturities 90 days or less) | $292.0m | $38.0m | $199.0m | ($181.0m) | ($21.0m) | $297.0m | ($214.0m) | $10.0m | ($583.0m) | $449.0m | |
| Net change in securities sold under agreements to repurchase and cash collateral for loaned securities | $561.0m | $815.0m | $1.1b | $16.0m | $499.0m | $42.0m | ($1.5b) | ($156.0m) | $3.9b | $1.9b | |
| Novation of contracts under reinsurance agreement | — | — | — | — | $0 | $0 | $3.1b | $491.0m | $0 | $2.2b | |
| Operating Expenses | — | — | — | — | $8.9b | $21.2b | $3.6b | $14.6b | $22.3b | $35.5b | |
| Operating Gains Losses | — | — | — | — | — | — | $2.8b | $878.0m | $3.5b | $971.0m | |
| Other Cash Adjustment Inside Changein Cash | — | — | — | — | — | ($2.1b) | $2.1b | $0 | $0 | — | |
| Other Non Cash Items | — | — | — | — | — | — | ($2.2b) | ($2.2b) | ($2.1b) | ($2.0b) | |
| Other invested assets | $1.1b | $1.3b | ($2.7b) | ($2.6b) | ($2.8b) | ($3.6b) | ($2.8b) | ($3.0b) | ($3.9b) | ($3.1b) | |
| Other, net | ($131.0m) | ($14.0m) | ($282.0m) | ($181.0m) | ($456.0m) | ($364.0m) | $2.2b | $645.0m | $830.0m | $848.0m | |
| Payables established under coinsurance with funds withheld | — | — | — | — | — | $0 | $0 | $8.2b | $277.0m | $0 | |
| Policy charges and fee income | ($1.9b) | ($2.5b) | ($2.2b) | ($2.6b) | ($2.7b) | ($2.3b) | ($2.5b) | ($2.2b) | ($2.1b) | ($2.0b) | |
| Policy loans | ($1.9b) | ($1.9b) | ($2.0b) | ($1.9b) | ($2.0b) | ($1.2b) | ($1.2b) | ($1.5b) | ($1.6b) | ($1.6b) | |
| Policy loans ceded | — | — | — | — | — | — | $0 | $0 | $44.0m | $0 | |
| Policyholders’ account deposits | $29.6b | $26.5b | $28.8b | $27.5b | $41.4b | $31.8b | $30.1b | $28.5b | $35.9b | $39.9b | |
| Policyholders’ account withdrawals | ($24.1b) | ($25.7b) | ($27.3b) | ($26.7b) | ($34.7b) | ($29.2b) | ($24.1b) | ($18.3b) | ($19.4b) | ($20.3b) | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | $163.0m | $126.0m | $201.0m | $109.0m | |
| Proceeds from Stock Options Exercised | $426.0m | $246.0m | $132.0m | $133.0m | $153.0m | $200.0m | $163.0m | $126.0m | $201.0m | $109.0m | |
| Proceeds from notes issued by consolidated VIEs | — | $0 | $0 | $971.0m | $0 | $0 | $137.0m | $1.4b | $1.4b | $1.6b | |
| Realized Investment Gains (Losses) | $2.2b | $432.0m | $2.0b | ($459.0m) | ($3.9b) | $4.0b | ($3.4b) | ($3.6b) | ($3.4b) | ($4.1b) | |
| Realized investment gains(losses), net | ($2.2b) | ($432.0m) | ($2.0b) | $459.0m | $3.9b | ($4.0b) | $3.4b | $3.6b | $3.4b | $4.1b | |
| Reinsurance payables | — | — | — | — | — | — | — | $0 | $175.0m | $0 | |
| Reinsurance recoverable | — | — | — | — | — | — | — | $0 | ($7.9b) | $0 | |
| Reinsurance recoverables established for Future policy benefits ceded | — | — | — | — | — | $0 | $0 | ($5.6b) | ($7.4b) | $0 | |
| Reinsurance related-balances | — | — | — | — | — | — | ($868.0m) | ($683.0m) | ($2.7b) | ($2.3b) | |
| Repayments of notes issued by consolidated VIEs | — | $0 | $0 | ($638.0m) | ($19.0m) | $0 | $0 | ($336.0m) | ($617.0m) | ($439.0m) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | ($1.5b) | ($1.0b) | ($1.0b) | ($1.0b) | |
| Restricted cash and restricted cash equivalents (included in “Other assets”) | $54.0m | $46.0m | $142.0m | $147.0m | $154.0m | $46.0m | $48.0m | $44.0m | $23.0m | $37.0m | |
| Sale Of Business | — | — | — | — | — | $132.0m | $422.0m | $0 | $0 | — | |
| Short-term investments | ($43.4b) | ($28.3b) | ($33.3b) | ($37.3b) | ($49.8b) | ($32.3b) | ($37.9b) | ($32.9b) | ($37.2b) | ($31.0b) | |
| Treasury Stock shares issued for stock-based compensation programs | $115.0m | $104.0m | $138.0m | $197.0m | $151.0m | $138.0m | $236.0m | $282.0m | $217.0m | $187.0m | |
| Unwind of Deferred policy acquisition costs ceded | — | — | — | — | — | $0 | $0 | $23.0m | $983.0m | $219.0m | |
| Net Cash Provided by (Used in) Operating Activities | $14.8b | $13.4b | $21.7b | $19.6b | $8.4b | $9.8b | $5.2b | $6.5b | $8.5b | $6.3b | |
| Cash flows from investing activities: | |||||||||||
| Net Investment Purchase And Sale | — | — | — | — | — | — | ($8.5b) | ($9.3b) | ($25.2b) | ($24.1b) | |
| Purchase Of Investment | — | — | — | — | — | — | ($118.6b) | ($95.6b) | ($130.2b) | ($118.6b) | |
| Sale Of Investment | — | — | — | — | — | — | $110.1b | $86.3b | $105.0b | $94.5b | |
| Net Other Investing Changes | — | — | — | — | — | — | ($98.0m) | ($676.0m) | ($50.0m) | ($207.0m) | |
| Payments for (Proceeds from) Other Investing Activities | $227.0m | $712.0m | $188.0m | $437.0m | $278.0m | $596.0m | $98.0m | $676.0m | $50.0m | $207.0m | |
| Net Cash Provided by (Used in) Investing Activities | ($21.6b) | ($11.9b) | ($21.6b) | ($17.0b) | ($16.2b) | ($5.3b) | ($7.6b) | ($12.1b) | ($28.6b) | ($25.9b) | |
| Cash flows from financing activities: | |||||||||||
| Issuance Of Debt | — | — | — | — | — | — | $2.8b | $2.1b | $2.9b | $2.8b | |
| Long Term Debt Issuance | — | — | — | — | — | — | $2.8b | $2.1b | $2.9b | $2.8b | |
| Net Issuance Payments Of Debt | — | — | — | — | — | — | $1.4b | ($232.0m) | $845.0m | $1.2b | |
| Net Long Term Debt Issuance | — | — | — | — | — | — | $1.7b | ($242.0m) | $1.4b | $774.0m | |
| Net Short Term Debt Issuance | — | — | — | — | — | — | ($214.0m) | $10.0m | ($583.0m) | $449.0m | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | — | $58.2b | $59.7b | $52.3b | $44.1b | $64.8b | $50.8b | $44.1b | $59.1b | $45.2b | |
| Proceeds from the issuance of debt (maturities longer than 90 days) | $2.7b | $1.2b | $2.9b | $3.0b | $3.0b | $268.0m | $2.7b | $716.0m | $1.4b | $1.2b | |
| Long Term Debt Payments | — | — | — | — | — | — | ($1.2b) | ($2.3b) | ($1.4b) | ($2.0b) | |
| Repayment Of Debt | — | — | — | — | — | — | ($1.2b) | ($2.3b) | ($1.4b) | ($2.0b) | |
| Repayments of debt (maturities longer than 90 days) | ($2.8b) | ($1.8b) | ($1.8b) | ($1.4b) | ($2.7b) | ($1.7b) | ($1.2b) | ($2.0b) | ($814.0m) | ($1.5b) | |
| Common Stock reissued for exercise of stock options | $426.0m | $246.0m | $132.0m | $133.0m | $153.0m | $200.0m | $163.0m | $126.0m | $201.0m | $109.0m | |
| Net Common Stock Issuance | — | — | — | — | — | — | ($1.5b) | ($1.0b) | ($1.0b) | ($1.0b) | |
| Common Stock Payments | — | — | — | — | — | — | ($1.5b) | ($1.0b) | ($1.0b) | ($1.0b) | |
| Payments for Repurchase of Common Stock | $2.0b | $1.2b | $1.5b | $2.5b | $500.0m | $2.5b | $1.5b | $1.0b | $1.0b | $1.0b | |
| Payments of Ordinary Dividends, Common Stock | $1.3b | $1.3b | $1.5b | $1.6b | $1.8b | $1.8b | $1.8b | $1.8b | $1.9b | $1.9b | |
| Cash Dividends Paid | — | — | — | — | — | — | ($1.8b) | ($1.8b) | ($1.9b) | ($1.9b) | |
| Cash dividends paid on Common Stock | ($1k) | ($1k) | ($2k) | ($2k) | ($2k) | ($2k) | ($2k) | ($2k) | ($2k) | ($2k) | |
| Common Stock Dividend Paid | — | — | — | — | — | — | ($1.8b) | ($1.8b) | ($1.9b) | ($1.9b) | |
| Net Other Financing Charges | — | — | — | — | — | — | $8.2b | $10.9b | $17.4b | $20.5b | |
| Proceeds from (Payments for) Other Financing Activities | ($131.0m) | ($14.0m) | ($282.0m) | ($181.0m) | ($456.0m) | ($364.0m) | $2.2b | $645.0m | $830.0m | $848.0m | |
| Net Cash Provided by (Used in) Financing Activities | $3.2b | ($1.3b) | $781.0m | ($1.6b) | $4.9b | ($3.0b) | $4.9b | $7.7b | $19.4b | $20.8b | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | ($159.0m) | $37.0m | ($254.0m) | $77.0m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | ($159.0m) | $37.0m | ($254.0m) | $77.0m | |
| Effect of foreign exchange rate changes on cash balances | $50.0m | $110.0m | $142.0m | $16.0m | $340.0m | ($309.0m) | ($159.0m) | $37.0m | ($254.0m) | $77.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $959.0m | $979.0m | ($2.6b) | ($921.0m) | $4.4b | $2.2b | ($943.0m) | $1.2b | |
| NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS | ($3.6b) | $355.0m | $959.0m | $979.0m | ($2.6b) | ($921.0m) | $4.4b | $2.2b | ($943.0m) | $1.2b | |
| Assets received, excluding Cash and cash equivalents | $3.2b | $2.7b | $816.0m | $3.2b | $703.0m | $5.4b | $8.2b | $2.3b | $11.7b | $108.0m | |
| CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF YEAR | $14.2b | $14.5b | $15.5b | $16.5b | $13.9b | $12.9b | $17.3b | $19.5b | $18.5b | $19.7b | |
| Cash and cash equivalents | $14.1b | $14.5b | $15.4b | $16.3b | $13.7b | $12.9b | $17.3b | $19.4b | $18.5b | $19.7b | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $15.5b | $16.5b | $13.9b | $12.9b | $17.3b | $19.5b | $18.5b | $19.7b | |
| Net assets transferred, excluding Cash and cash equivalent | — | — | — | — | — | $0 | $0 | $1.4b | $6.7b | $6.1b | |
| Restricted Cash and Investments, Current | — | $45.0m | — | — | — | — | — | — | — | — | |
| Total cash, cash equivalents, restricted cash and restricted cash equivalents | $14.2b | $14.5b | $15.5b | $16.5b | $13.9b | $12.9b | $17.3b | $19.5b | $18.5b | $19.7b | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | $4.4b | $2.2b | ($943.0m) | $1.2b | |
| Interest Paid Supplemental Data | — | — | — | — | — | — | $1.5b | $1.6b | $2.0b | $1.9b | |
| Interest paid | $1.3b | $1.2b | $1.4b | $1.5b | $1.5b | $1.5b | $1.5b | $1.6b | $2.0b | $1.9b | |
| Income Taxes Paid, Net | $770.0m | $185.0m | $760.0m | $1.3b | $287.0m | $1.7b | $1.1b | $895.0m | $756.0m | $1.4b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.